Back
Marker Therapeutics Vs. Armata Pharmaceuticals Industry Stock Comparison
Sell
33
MRKR
Marker Therapeutics
Last Price:
3.50
Seasonality Move:
8.13%
Buy
87
ARMP
Armata Pharmaceuticals
Last Price:
2.69
Seasonality Move:
12.82%
Sell
33
Marker Therapeutics (MRKR)
is a Sell
Is Marker Therapeutics a Buy, Sell or Hold?
- The current Marker Therapeutics [MRKR] share price is $3.64. The Score for MRKR is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
- MRKR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
87
Armata Pharmaceuticals (ARMP)
is a Buy
Is Armata Pharmaceuticals a Buy, Sell or Hold?
- The current Armata Pharmaceuticals [ARMP] share price is $2.72. The Score for ARMP is 87, which is 74% above its historic median score of 50, and infers lower risk than normal.
- ARMP is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
MRKR Stock Price Chart
What is Marker Therapeutics's stock price today?
-
The Marker Therapeutics share price today is $3.64
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MRKR is experiencing selling pressure, which indicates risk of future bearish movement.
ARMP Stock Price Chart
What is Armata Pharmaceuticals's stock price today?
-
The Armata Pharmaceuticals share price today is $2.72
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ARMP is experiencing selling pressure, which indicates risk of future bearish movement.
MRKR Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.14 | Buy |
Relative Strength Index (14 RSI): | 48.96 | Sell |
Chaikin Money Flow: | -16950 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (3.2 - 4.28) | Sell |
Bollinger Bands (100): | (2.94 - 4.8) | Sell |
ARMP Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.04 | Buy |
Relative Strength Index (14 RSI): | 67.14 | Buy |
Chaikin Money Flow: | -21890 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (2.24 - 2.48) | Buy |
Bollinger Bands (100): | (2.25 - 2.77) | Buy |
MRKR Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 3.86 | Sell |
20-day SMA: | 3.96 | Sell |
50-day SMA: | 3.27 | Buy |
200-day SMA: | 4.04 | Sell |
8-day EMA: | 3.85 | Sell |
20-day EMA: | 3.78 | Sell |
50-day EMA: | 3.61 | Buy |
200-day EMA: | 3.87 | Sell |
ARMP Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 2.39 | Buy |
20-day SMA: | 2.37 | Buy |
50-day SMA: | 2.34 | Buy |
200-day SMA: | 2.84 | Sell |
8-day EMA: | 2.46 | Buy |
20-day EMA: | 2.39 | Buy |
50-day EMA: | 2.39 | Buy |
200-day EMA: | 2.63 | Buy |
Marker Therapeutics Earnings Growth & MRKR Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.71 per share, and a decrease next year of $0.03 per share.
Armata Pharmaceuticals Earnings Growth & ARMP Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.13 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.01 per share, and an increase next year of $0.52 per share.
Marker Therapeutics Technical Analysis
Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | Nov | |||||||||
31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Armata Pharmaceuticals Technical Analysis
Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | Nov | |||||||||
31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |